Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Antranik Mavousian
Observed name:
Mavousian, Antranik
Institutions:
Institute of Cancer Research,
Breast Cancer Now
Observed institutions:
Institute of Cancer Research,
Wellcome/MRC Cambridge Stem Cell Institute,
University of Cambridge,
Breast Cancer Now
ORCID:
0009-0000-7479-7786
Observed ORCID:
0009-0000-7479-7786
OpenAlex ID:
A5049300376
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
2021
·
Petra Mlcochova
, Steven A. Kemp
, et al.
·
Nature
·
1,452
PDF
Metastatic-niche labelling reveals parenchymal cells with stem features
2019
·
Luigi Ombrato
, Emma Nolan
, et al.
·
Nature
·
218
SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
2021
·
Petra Mlcochova
, Steven Kemp
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
108
PDF
SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
2021
·
Petra Mlčochová
, Steven A. Kemp
, et al.
·
Greater South Information System
·
61
Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
·
Clinical Cancer Research
·
41
Bio‐assembling Macro‐Scale, Lumenized Airway Tubes of Defined Shape via Multi‐Organoid Patterning and Fusion
2021
·
Ye Liu
, Catherine Dabrowska
, et al.
·
Advanced Science
·
40
PDF
Author Correction: Metastatic-niche labelling reveals parenchymal cells with stem features
2019
·
Luigi Ombrato
, Emma Nolan
, et al.
·
Nature
·
10
PDF
Mitotic single-stranded DNA suppression by DDIAS
2026
·
Yibo Xue
, Faisal Bin Rashed
, et al.
·
Molecular Cell
·
5
Supplementary Figure 2 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Table 1 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Figure 2 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Figure 1 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Figure 4 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Table 1 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Figure 3 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Table 2 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Video 1 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Table 2 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Figure 3 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Figure 1 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
PDF
Data from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Video 1 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Figure 6 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Supplementary Figure 4 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Figure 3 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024
·
Anthony Cheung
, Alicia M. Chenoweth
, et al.
Show more works
View as search
Works count:
46
Citation count:
1,938
H-index:
7
I10-index:
7
Year
Topic
Type